
With the adaption of two EU regulations by the European Parliament and Council and the signature of the Agreement on a Unified Patent Court, the unitary patent system seems soon to become a reality. The new system is based on a so-called ‘enhanced cooperation’ pursuant to Art 329 TFEU. Spain and Italy, the only EU Member States that chose not to participate, tried to prevent the other countries from proceeding without them by taking their case to the Court of Justice of the EU. They failed: yesterday, the Court dismissed their complaints against enhanced cooperation.
Read moreLundbeck’s patents protecting their blockbuster Cipralex® have been subject to invalidation actions around the globe for already quite some years. Cipralex® is an antidepressant drug which contains as the active substance Escitalopram, the (S)-enantiomer of the racemic mixture (citalopram) marketed amongst others as Cipramil®.
Read moreOn 15 April 2013 the Australian Patents Act 1990 will see some major changes. From this date on, patent applications for which applicants have not submitted the request for examination will be subject to more strict requirements.
Read moreThe international agreement for establishing a Unified Patent Court (UPC) was signed today in Brussels. It will ensure the uniform applicability of patent law throughout the territories of the signatory countries. NLO keeps a close watch on all developments regarding the Unitary Patent.
Read moreBy Peter ten Haaft and Thea van der Wijk
On September 16, 2011, President Obama has signed the America Invents Act (AIA) into law. The act is regarded as the most significant reform of the United State’s Patent Act since 1952. The full text of the act, comprising many different provisions each with different effective dates, can be found here. At least the next 20 years both the new and the old systems have to be taken into account.
Read more